The function and mechanism of LINC01583 on Osimertinib resistance in non-small cell lung cancer

In this study, we revealed LINC01583 as a key oncogenic driver that promotes both NSCLC progression and Osi resistance by functioning as a competing endogenous RNA (ceRNA) for miR-4640-5p, thereby upregulating its target gene CHD8.

Authors

Institutions

Publication Details

Journal
Molecular and Cellular Probes
Published
2026-02-12
DOI
https://doi.org/10.1016/j.mcp.2026.102067
Primary Topic
MicroRNA in disease regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The function and mechanism of LINC01583 on Osimertinib resistance in non-small cell lung cancer

Shu Xu, Ting Xu, Liu Na, X. Wang
Molecular and Cellular Probes
MicroRNA in disease regulation
article

The function and mechanism of LINC01583 on Osimertinib resistance in non-small cell lung cancer

Shu Xu, Ting Xu, Liu Na, X. Wang
article en

Abstract

In this study, we revealed LINC01583 as a key oncogenic driver that promotes both NSCLC progression and Osi resistance by functioning as a competing endogenous RNA (ceRNA) for miR-4640-5p, thereby upregulating its target gene CHD8.

Molecular and Cellular ProbesVol. 87
Nanjing Brain Hospital (CN), Nanjing Chest Hospital (CN)
Good health and well-being
Openalex Percentile: Top 60%
MicroRNA in disease regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.